Overview; Trade recap; Fundamentals; Equity What's this? Return. Find the latest TAKEDA PHARMACEUTICAL CO LTD (TKPHF) stock quote, history, news and other vital information to help you with your stock trading and investing. TAKN.MX is Takeda Pharmaceutical Company Limited's stock. Price (EUR) 49.35 -% (-) 0RN3 TAKEDA PHARMACEUTICAL ORD SHS. S&P. Medical Sector. It is one of many ways to value Takeda Pharmaceutica and is calculated by multiplying the price of the stock by the number of shares issued. Market Cap (Previous Close): 28.18 B Share Volume (Previous Close): 7.84 M Price in USD (Last): 16.663. TKPHF: Get the latest Takeda Pharmaceutical stock price and detailed information including TKPHF news, historical charts and realtime prices. 21st out of 771 stocks. Average price in 50 days is 441.35$. Takeda Pharmaceutical has received a consensus rating of Buy. Consensus Rating. Market Cap ¥5.74T; Shares Outstanding 1.58B; Public Float 1.51B; Beta 0.79; Rev. 1.58B. 0.96. Real time TAKEDA PHARMACEUTICAL CO Ltd. (TKPHF) stock price quote, stock graph, news & analysis. TAK - Takeda Pharmaceutical Co Ltd Stock quote - CNNMoney.com Markets Home to the EUCAN commercial organization, the site includes the Vaccines Business Unit & several key global functions. Quentin Horgan, Pharmaceutical Data and Analytics at GlobalData, comments: “Takeda is the new entrant in the list, replacing Biogen Inc. Takeda’s merger with Shire coupled with strong growth in drugs such as Azilva (Azilsartan), which reported a 36% increase in … 🧢 Market Cap; 0.75%: $56.85b 🏋️‍♀️ Weight Rank Across All Funds 🧮 Price to Sales; 41: 0 🎫 Ark Ownership Percent 🐻 Short Percent; 0.62% ↩️ Dividend Yield 🌏 Country; 5% 🇯🇵 Japan Takeda will add its roughly $33 billion market cap to Shire's, which is north of $49 billion. Market Cap$57.35 billion. Lyft Stocks - Lyft Stocks - Feb 16, 2021 - Polygon Management Ltd. Buys Takeda Pharmaceutical Co, Freeline Therapeutics Holdings PLC, Canopy Growth Corp, Sells Norwegian Cruise Line Holdings, Lyft Inc, American Electric Power Co Inc | Fintech Zoom - The tie-up assigns rights to Ovid’s pipeline lead, soticlestat, to the Japanese group, which now plans to start phase III trials in Dravet and Lennox-Gastaut syndromes. Market Cap all cash no debt. Dividend Rate (Yield) 180.00 (4.87%) Beta. The new Takeda will be close in size to Bristol-Myers Squibb ( BMY ) and Eli Lilly ( LLY ). Find market predictions, 4502 financials and market news. As of February 2021 Takeda Pharmaceutical's TTM revenue is of $30.76 B. companies: 4,690 total market cap: $88.111 T. Global ranking (current) Ranking by countries. Stock Info. + 2.5 X market cap in royalties WITH no cost to company for trail 3 and commercialization. View real-time stock prices and stock quotes for a full financial overview. Get the latest Takeda Pharmaceutical Co Ltd (TAK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. P/E Ratio (EPS) 2,184.37 (28.30) Recent News. 30.98: Dividend (Yield %) 4.75: Advanced Charting. Takeda reported 5902B in Market Capitalization for its third fiscal quarter of 2020. Stock exchange Mexico (Currency MXN). Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. Track 1 instrument . One company to break the top 20 was Takeda Pharmaceutical, which grew to $63.4 billion in the first quarter as the result of its acquisition of Dublin-based Shire. Market cap 1.10T Stock exchange Mexico (Currency MXN). Shares Outstanding. Get the latest Takeda Pharmaceutical Co Ltd (4502) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Takeda Pharmaceutical is advancing the Japanese pharma giant's immune-oncology portfolio through the acquisition of the immunotherapy pioneer Maverick Therapeutics. Market Cap Revenue; Medical: Medical - Drug Manufacturing: $54.984B: $30.200B: Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Latest Stock Picks Investing Basics Premium Services. Takeda’s Market Cap during Q1 2019 grew to US$63.4bn, at the back of its takeover of Irish pharmaceuticals firm Shire Plc. Explore commentary on Takeda Pharmaceutical Co. Ltd… View detailed financial information, real-time news, videos, quotes and analysis on Takeda Pharmaceutical Co. Ltd. (NYSE:TAK). Takeda Pharmaceutical Co Ltd (NYSE: TAK) has asked regulators to approve the use of Moderna Inc’s (NASDAQ: MRNA) COVID-19 vaccine (mRNA-1273 or TAK-919). Together, the top 20 pharma companies reported an aggregated market cap of $2.63 trillion—yes, trillion!—in Q1 2019, an increase of 6.2% compared to $2.47 trillion on December 31, 2018. Takeda Pharmaceutica Market Capitalization is currently at 53.07 B. View live TAKEDA PHARMACEUTICAL CO LTD chart to track its stock's price action. Pivot, Resistance Levels and Support Levels For Stop Loss and … Next Earnings Date5/12/2021 (Estimated) OptionableOptionable. Market Capitalization is the total market value of Takeda Pharmaceutica's equity. Get Takeda Pharmaceutical Co Ltd (4502.T-JP:Tokyo Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. 🧢 Market Cap; 4.04%: $56.85b 🏋🏿‍♂️ Weight Rank In ARKG 🧮 Price to Sales; 7: 0 🏋️‍♀️ Weight Rank Across All Funds 🐻 Short Percent; 38 🎫 Ark Ownership Percent ↩️ Dividend Yield; 0.61%: 5% 🌏 Country 🇯🇵 Japan 56th out of 1,968 stocks. Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. As at 05.03.21 06:56:40 - All data delayed at … Takeda's Europe & Canada Business Unit (EUCAN) operates across 30 countries and has its hub in Zurich, Switzerland. In depth view into Takeda Pharmaceutical Market Cap including historical data from 2010, charts, stats and industry comps. Takeda Pharmaceutical has a market cap of $57.32 B, which represents its current share price of $17.55 multiplied by its outstanding share number of 3152.75. Pharmaceutical Preparations Industry. General. Takeda Pharmaceutical Co (TKPHF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. TKPHF | Complete Takeda Pharmaceutical Co. Ltd. stock news by MarketWatch. Country Name: USA Exchange: PINK Sector: Other Type: Common Stock Industry: Other . Prices and Markets > TAKEDA PHARMACEUTICAL CO LTD; TAKEDA PHARMACEUTICAL CO LTD. Share . Average daily volumn in 3 months . Market Cap (MIL) 5,979,240.00: Forward P/E. Open / Last close - / 49.35 . Forecast data: 52 Week High: 18.328 52 Week Low: 15.958 45-Day Moving Average: 22.973 90-Day Moving Average: 22.666. 5.87T. Market Cap. Find real-time TAK - Takeda Pharmaceutical Co Ltd stock quotes, company profile, news and forecasts from CNN Business. High / Low-/ -Bid / Offer-/ -Special Condition: - Trading Status: No Active Session . Failure in Angelman syndrome had laid Ovid low, but today the group got a reprieve thanks to a deal amendment with Takeda that brought an up-front fee of $196m – more than the value of Ovid’s market cap last night. 5 - 4 - 3 - 2 - 1 - 3.5 Analyst's Opinion. MarketRank ™ Overall MarketRank ™ 2.04 out of 5 stars. Next Event .